Review Article
Traditional Chinese Medicine for Senile Dementia
(a) Memory-improving and neuro-protective effects of Radix polygalae |
| Test | Test materials/dose | Test model | Endpoint/biomarkers | Effects | Mechanisms | Reference |
| Clinic | Extracts 300 mg/d, 4 w | Healthy Korean elderly with subjective memory impairment and mild cognitive impairmentdouble-blind, placebo-controlled, randomized, parallel study | Korean version of California verbal learning testSelf-ordered pointing test | Improve verbal memory No adverse events, except mild dyspepsia | N.A. | [32, 33] |
| In vivo | Extracts i.p., 2 mg/kg | Innate rats | Nestin/BrdU Tuj1/BrdU | Improve memory Promote neuro-genesis | Promote proliferation Promote neurite outgrowth | [34] | Extracts | Stress-treated rats | Glucose utilization Cell adhesion molecule | Improve memory | Increase glucose utilization Increase total NCAM | [35] | Extracts 2 g/kg, 1–3 w | NBM-lesioning rats | Neurological test Step-through test | Improve memory | N.A. | [36] | Extracts i.p., 10 mg/kg | Scopolamine-treated rats | Passive avoidance test water maze test AChE | Improve memory | Inhibit AChE | [36] |
| In vitro | Extracts 0.5–5 μg/mL | Rat primary neurons exposed to Glutamate or Aβ | Cell viability | Protect neurons | N.A. | [37] | Extracts 0.05–5 μg/mL | Rat cerebellar granule neurons exposed to NMDA | Glutamate release (Ca2+)i/ROS | Protect neurons | N.A. | [38] | Extracts 0.1–100 μg/mL | Rat cortical neurons exposed to Aβ 25–35 | Axonal length Neuro-filament-H/MAP-2Cell viability | Activate axonal extension Protect neurons | N.A. | [39] |
|
|
Acetylcholinesterase (AChE); bromodeoxyuridine (BrdU); microtubule-associated protein-2 (MAP-2); nucleus basalis magnocellularis (NBM); neural cell adhesion molecule (NCAM); N-methyl-D-aspartic acid (NMDA); reactive oxygen species (ROS); β amyloid (Aβ); not available (N.A.); intraperitoneally (ip.).
|
(b) Memory-improving and neuro-protective effects of active components from Radix polygalae |
| Test | Test materials/dose | Test model | Endpoints/biomarkers | Effects | Mechanisms | Reference |
| In vivo | Sinapic acid 10–100 mg/kg | Scopolamine-treated rats | Radial maze test | Improve memory | N.A. | [42, 43] | Sinapic acid 3–100 mg/kg, 1 h | Scopolamine-treat mice Basal forebrain lesioning mice | Step-through test Ach/ChAT | Improve memory | N.A. | [49] | Tenuifolin 20–80 mg/kg, 15 d | Aged mice Dysmnesia mice | Step-down test Y maze trial AChE,NE,DA,5-HT | Improve memory | Increase NE and DA Inhibit AChE | [45] | Tenuigenin 18.5–74 mg/kg | Aβ 1-40-treated rats ibotenic acid-treated rats | Step-through test AchE, ChAT | Improve memory | Cholinergic | [46] | Acylated oligosaccharides1–10 mg/kg | Scopolamine-treated rats | Step-through test | Improve memory | Cholinergic | [44] |
| In vitro | Tenuigenin 1–4 μg/mL | APP-transfected SH-SY5Y cells | Fluorescence resonance energy transfer | Inhibit Aβ secretion | Inhibit BACE1 | [47] | Onjisaponin 10 μM | Serum deficiency or glutamate-treated PC12 cells | Cell survival | Protect PC 12 cells | N.A. | [48] |
|
|
Acetylcholine (Ach); acetylcholinesterase (AChE); choline acetyltransferase (ChAT); 5-hydroxytryptamine (5-HT); dopamine (DA); norepinephrine (NE); beta-site APP cleaving enzyme (BACE); amyloid precursor protein (APP); β amyloid (Aβ); not available (N.A.).
|